Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cancer stem cell mimicry for immune evasion and therapeutic resistance
Phei Er Saw, Qiang Liu, Ping‐Pui Wong, et al.
Cell stem cell (2024) Vol. 31, Iss. 8, pp. 1101-1112
Closed Access | Times Cited: 30

Showing 1-25 of 30 citing articles:

The hallmarks of cancer immune evasion
Claudia Galassi, Timothy A. Chan, Ilio Vitale, et al.
Cancer Cell (2024) Vol. 42, Iss. 11, pp. 1825-1863
Closed Access | Times Cited: 70
Clinical advances of mRNA vaccines for cancer immunotherapy
Alexey V. Yaremenko, Muhammad Muzamil Khan, Xueyan Zhen, et al.
Med (2025) Vol. 6, Iss. 1, pp. 100562-100562
Closed Access | Times Cited: 6
Cancer stem cells and niches: challenges in immunotherapy resistance
Yonglong Pan, Chaoyi Yuan, Chenglong Zeng, et al.
Molecular Cancer (2025) Vol. 24, Iss. 1
Open Access | Times Cited: 2
Targeting the immune privilege of tumor-initiating cells to enhance cancer immunotherapy
Chen Yang, Haigang Geng, Xupeng Yang, et al.
Cancer Cell (2024) Vol. 42, Iss. 12, pp. 2064-2081.e19
Closed Access | Times Cited: 13
Tumor Metastasis: Mechanistic Insights and Therapeutic Intervention
Lin Tang, Peng Shen, Xiaoying Zhuang, et al.
MedComm – Oncology (2025) Vol. 4, Iss. 1
Open Access | Times Cited: 1
Exosome-transmitted LUCAT1 promotes stemness transformation and chemoresistance in bladder cancer by binding to IGF2BP2
Yonghao Zhan, Zhenzhen Zhou, Zhaowei Zhu, et al.
Journal of Experimental & Clinical Cancer Research (2025) Vol. 44, Iss. 1
Open Access | Times Cited: 1
Stemness in solid malignancies: coping with immune attack
Judith Agudo, Yuxuan Miao
Nature reviews. Cancer (2024)
Closed Access | Times Cited: 8
Exosome crosstalk between cancer stem cells and tumor microenvironment: cancer progression and therapeutic strategies
Qi Li, Guangpeng He, Yifan Yu, et al.
Stem Cell Research & Therapy (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 8
Chitosan-based nanoarchitectures for siRNA delivery in cancer therapy: A review of pre-clinical and clinical importance
Xiaobo Bian, Xiaopeng Yu, Shiyang Lu, et al.
International Journal of Biological Macromolecules (2024), pp. 137708-137708
Closed Access | Times Cited: 5
Carbohydrate polymer-functionalized metal nanoparticles in cancer therapy: A review
Xi Zhou, Dongbin Zhang, Mingming Han, et al.
International Journal of Biological Macromolecules (2025) Vol. 306, pp. 141235-141235
Closed Access
Stem cell and organoid modeling in cancer study
Tingyi Li
Highlights in Science Engineering and Technology (2025) Vol. 129, pp. 171-175
Closed Access
A Hybrid Manganese Nanoparticle Simultaneously Eliminates Cancer Stem Cells and Activates STING Pathway to Potentiate Cancer Immunotherapy
Yaping Wu, Pengfei Diao, Yayun Peng, et al.
ACS Nano (2025)
Closed Access
Autophagy in adult stem cell homeostasis, aging, and disease therapy
Ke Zhao, Indigo T.C. Chan, Erin H. Y. Tse, et al.
Cell Regeneration (2025) Vol. 14, Iss. 1
Open Access
Development and Application of Organic Sonosensitizers in Cancer Therapy
Yuhan Ding, Yuchen Yang, Ömer Aras, et al.
Aggregate (2025)
Open Access
SNORA74A Drives Self‐Renewal of Liver Cancer Stem Cells and Hepatocarcinogenesis Through Activation of Notch3 Signaling
Ziheng Zhou, Yang Gu, Zhibin Yi, et al.
Advanced Science (2025)
Open Access
Inside a Metastatic Fracture: Molecular Bases and New Potential Therapeutic Targets
Alessandro Bruschi, Andrea Sambri, Michele Fiore, et al.
Cancer Medicine (2025) Vol. 14, Iss. 9
Open Access
KLF7-regulated ITGA2 as a therapeutic target for inhibiting oral cancer stem cells
Xin Qi, Zhou Jiang, Pan Wang, et al.
Cell Death and Disease (2025) Vol. 16, Iss. 1
Open Access
Neoplastic immune mimicry is a generalizable phenomenon in breast cancer and epithelial CD69 enables early tumor progression
Eric B. Berens, Sokchea Khou, Elaine Huang, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Closed Access
The ‘inflammazone’ in chronic inflammatory diseases: psoriasis and sarcoidosis
Phei Er Saw, Erwei Song
Trends in Immunology (2025)
Closed Access
CPT1A-mediated MFF succinylation promotes stemness maintenance in ovarian cancer stem cells
Yaqin Zhu, Shuting Chen, Hong Su, et al.
Communications Biology (2025) Vol. 8, Iss. 1
Open Access
Breast Cancer Stem Cell Heterogeneity, Plasticity and Treatment Strategies
Mengting Chen, Suling Liu
(2025)
Open Access
Exosomes in Precision Oncology and Beyond: From Bench to Bedside in Diagnostics and Therapeutics
Emile M. Youssef, Dannelle Palmer, Brandon Fletcher, et al.
Cancers (2025) Vol. 17, Iss. 6, pp. 940-940
Open Access
Unraveling the triad of hypoxia, cancer cell stemness, and drug resistance
Tongxuan Shang, Ziqi Jia, J. Li, et al.
Journal of Hematology & Oncology (2025) Vol. 18, Iss. 1
Open Access
Metabolic Reprogramming in Cholangiocarcinoma Cancer Stem Cells: Emerging Therapeutic Paradigms
Qi Wang, Timothy E. Long, Peili Tang, et al.
Cancer Letters (2025), pp. 217714-217714
Closed Access
Characteristic, Regulation and Targeting Strategies of Cancer Stem Cells and Their Niche in Digestive System Tumors
Zhenzhen Chen, Huixiong Qi, Yapeng Xue, et al.
MedComm – Oncology (2025) Vol. 4, Iss. 2
Open Access
Page 1 - Next Page

Scroll to top